Nanjing Baifu Laser: Pioneering Domestic High-End Aesthetic Laser Devices to Compete with Global Giants

With rising living standards, deepening global aging, and the booming beauty economy, demand for cosmetic treatments and anti-aging solutions has become increasingly indispensable. The sustained release of consumer demand in healthcare and aesthetics has driven continuous growth in the medical and aesthetic markets.

As upstream products in the medical and aesthetic industry chain, laser medical devices will continue to benefit from overall industry growth, offering substantial market potential. Coupled with consumers’ demand for safety and stability in aesthetic procedures, the development of laser medical devices is currently in an upward trajectory.

According to data from the China Association of Medical Device Industry, most major hospitals across China have established laser medical centers, and over 80% of hospitals are equipped with laser medical devices. Meanwhile, many small and medium-sized hospitals have also set up laser treatment rooms, leading to a significant increase in demand for laser medical equipment within China’s healthcare sector.

According to the online press conference for the "2020 China Laser Industry Development Report," China's laser medical devices still rely mainly on imports, and the localization rate of medical laser equipment remains low. However, in recent years, driven by growing market demand and strong national support, a number of exemplary private enterprises have emerged in China's medical laser device manufacturing sector. Nanjing Baifu Laser Technology Co., Ltd. (hereinafter referred to as "Nanjing Baifu") is one such company.

Nanjing Baifu is targeted atHigh-End Laser Aesthetic Medicine SectorwithDigitalization and IntelligenceA high-tech enterprise centered on medical solutions. The company is currently dedicated to the independent research and development, manufacturing, sales, and scientific research services of innovative products in the fields of dermatology, plastic surgery, rehabilitation medicine, and general health.

Currently, breakthroughs in the localization of certain devices have been achieved. The company has independently developed a series of laser products, including Nd:YAG Q-switched lasers, 1064 nm long-pulse lasers, 755 nm alexandrite long-pulse lasers, 2940 nm erbium lasers, and 1064/532 nm picosecond lasers. The relevant technical indicators have reached a leading level in China.

According to Jia Yangchun, founder of Nanjing Baifu, most participants in China’s medical aesthetics industry are equipment distributors, with few companies possessing both the willingness and capability for independent research and development. Although the market is substantial, there are relatively few players competing for a share.

To enter the medical aesthetics laser market, one must first overcome two “major hurdles.”

The first major hurdle is called “technical barriers.”Due to foreign technological monopolies and a domestic gap in related technologies, there are no ready-made “shoulders of giants” to stand on. New entrants seeking a broader vision must advance step by step through their own technological development. This inevitably imposes exceptionally high demands on R&D capabilities. In addition to stringent professional requirements for technical personnel, substantial financial support is also essential.

The second major hurdle is the “regulatory approval barrier.”Domestic market approval typically takes 2–3 years, requiring entrants to possess strong resilience and mental fortitude—enduring the “cold bench” and the loneliness of unprofitability. However, once certification is obtained, products can enter a phase of rapid volume expansion, yielding substantial returns.

Therefore, although the scenery on the other side of the “mountain” is picturesque and enticing, domestic manufacturers must still overcome the aforementioned two major challenges if they wish to reap the sweet and desirable fruits.

Nanjing Baifu has its own proprietary solutions to address these two major challenges.

On one hand, we are recruiting top talent from the laser industry, expanding our R&D team, and increasing R&D investment.

Jia Yangchun, Founder and General Manager, graduated from the University of Salamanca in Spain with a Master’s degree in Linguistics and is multilingual. Previously worked in sales at a well-known enterprise in the optoelectronics industry, boasting over 16 years of experience in selling medical aesthetic optoelectronic equipment. Founded Zhengzhou Baishilaifu Electronic Technology Co., Ltd. in 2011, and established Shenzhen Leike Laser Precision Co., Ltd. in 2017, initiating research and development in high-end laser technologies.Currently responsible for defining the market positioning and sales strategy for Nanjing Baifu's products.

Director Niu, R&D Director,Graduated from the Shanghai Institute of Optics and Fine Mechanics, Chinese Academy of Sciences, with over ten years of experience working in laser technology startups.Currently responsible for project R&D and the development of production systems.

Product Manager, Director Chen, holds a Ph.D. in Laser Science from the Anhui Institute of Optics and Fine Mechanics, Chinese Academy of Sciences, and has over 10 years of experience in laser product R&D and team management.Currently responsible for the R&D of laser system platforms.

August 2021, Nanjing BaifuSecured Tens of Millions in Pre-A Financing from Northern Light Venture Capital. With capital support, Nanjing Baifu has entered a fast lane of development, rapidly expanding its team to approximately 160 employees, among whomThe R&D team accounts for one-quarter of the total workforce., including global leaders in laser medicine from institutions such as MIT and Harvard.

On the other hand, leveraging its own advantages to actively expand overseas, while closely pursuing domestic approval applications.

Leveraging Jia Yangchun’s educational background in Spanish and his extensive professional experience and resource accumulation in overseas sales, Nanjing Baifu currently focuses primarily on exports, targeting markets in Spanish-speaking countries.

Meanwhile, we should expedite the application for medical device approval in China, advancing both domestic and international efforts in parallel.

Due to the development gap between the domestic and international medical aesthetics laser industries, laser equipment used by medical aesthetics institutions in China is currently dominated by imported devices. In such a high-barrier industry characterized by import monopoly, how can Nanjing Baifu Laser Technology Co., Ltd. establish its own competitive advantage?

Jia Yangchun stated that the company’sA major competitive advantage is high cost-effectiveness.

“Due to the high prices of imported equipment, the procurement costs for hospitals and medical aesthetics institutions are extremely high, which has actually limited the promotion of medical aesthetic laser devices in China. We hope to lower the entry barrier for hospitals and medical aesthetics institutions by producing domestically made medical aesthetic laser equipment and providing full-treatment-cycle solutions.”

According to Jia Yangchun, among high-end laser-based medical aesthetic devices, erbium lasers present the greatest technical challenges, followed by alexandrite lasers, ruby lasers, picosecond lasers, and dye lasers. In skin management, different types of lasers are required for various anatomical areas and distinct treatment and care needs, which accounts for the wide variety of laser device categories available.

Nanjing Baifu currently focuses on three core products—2940nm Erbium Laser, Picosecond Laserand755nm Alexandrite Laser, and its relevant technical indicators have already reached a leading level in China. In the future, Nanjing Baifu will develop more intelligent photoelectric medical aesthetic devices tailored for Chinese patients.

Nanjing Baifu’s Three Core Products

Meanwhile, Nanjing Baifu United HospitalEstablish a Big Data Database for High-End Domestic Laser Dermatology, fromPreoperativeDiagnosticIntelligent Recognition System Development, toIntraoperativeRecommended Optimal Treatment Plan, toIntelligent Skin Function Assessment System for Postoperative Care, covering the entire treatment cycle and leveraging digital tools to enhance the precision of photoelectric therapies.

Jia Yangchun is ambitious about the future plans of Nanjing Baifu—

• On the basis of stabilizing our core market in Latin America, we will continue to deepen our presence by strategically selecting locations to establish subsidiaries, as well as building exhibition centers and after-sales service centers;

• Establish an Arabic-speaking sales team to open up the Arabic market, and rapidly penetrate local markets through exhibitions, online promotion, and clinical product presentations.

• During this period, await approval of domestic products; upon approval, rapidly scale up volume in the Chinese market to capture market share.

Nanjing Baifu is currentlySeeking the Next Round of Financing, used for productionProduct R&D iteration, clinical registration, academic promotion, marketingetc.